ArticleProceedings of the National Academy of Sciences of the United States of America2025

Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery.

Yixin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.